Clinical Research Directory
Browse clinical research sites, groups, and studies.
Estrogen Deficiency on Cardiovascular Risk
Sponsor: Milton S. Hershey Medical Center
Summary
To explore how estrogen deficiency impacts the blood pressure (BP) and sympathetic nerve activity (SNA), and how it impacts the production of the key pro-inflammatory mediators such as Tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). It is hypothesized that estrogen deficiency increases BP, SNA and the pathway activities of the key pro-inflammatory mediators. Those effects are impacted through the downregulation of the estrogen receptor.
Official title: Estrogen Deficiency on Cardiovascular Risk: Sympathetic Responses and Pro-inflammatory Cytokines
Key Details
Gender
FEMALE
Age Range
54 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-09
Completion Date
2028-11
Last Updated
2025-11-17
Healthy Volunteers
Yes
Interventions
Placebo
Subjects will be assigned to 1 week of transdermal placebo patch.
Estradiol
Subjects will be assigned to 1 week of transdermal estradiol (0.05 mg/day) patch.